Abstract
Eight premenopausal women with cancer had blood drawn for analysis of brain-derived neurotrophic factor (BDNF) and müllerian-inhibiting substance (MIS) before and 3 months after receiving chemotherapy. Unlike MIS, BDNF levels were not reduced after chemotherapy.
Original language | English (US) |
---|---|
Pages (from-to) | 1790-1793 |
Number of pages | 4 |
Journal | Fertility and sterility |
Volume | 95 |
Issue number | 5 |
DOIs | |
State | Published - Apr 2011 |
Externally published | Yes |
Keywords
- Anti-müllerian hormone
- brain-derived neurotrophic factor
- cancer
- chemotherapy
- müllerian-inhibiting substance
- ovarian reserve
ASJC Scopus subject areas
- Reproductive Medicine
- Obstetrics and Gynecology